Abstract
Levetiracetam (LEV) is an antiepileptic drug commonly used in the treatment of epilepsy because of its excellent safety profile in all age groups. It is remarkable that there are no studies evaluating the toxic effects of this drug on the male reproductive system, as it is commonly used in male patients of reproductive age. From this point of view, our aim was to evaluate the possible toxic effects of LEV on the male reproductive system. Therefore, LEV was administered to male rats orally at 50, 150, and 300 mg/kg for 70 consecutive days. At the end of this period, alterations to body and organ weights were calculated, and sperm concentration, motility, and morphology were investigated by a computer-assisted sperm analysis system. Sperm DNA damage was determined by comet assay and histopathological examination of the testes was carried out. Serum testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) levels were measured by ELISAs to determine the effects of hormonal status, while glutathione, superoxide dismutase, catalase, and malondialdehyde levels in the testes were measured by colorimetric assay kits to determine the role of oxidative status in potential toxicity. According to the results, sperm quality was decreased by LEV treatment in a dose-dependent manner. LEV induced significant DNA damage in the 150 and 300 mg/kg LEV-administered groups. Histopathology of the testes showed that LEV resulted in testicular injury in the 300 mg/kg LEV-administered group. Serum testosterone, FSH, and LH levels were significantly decreased in the 300 mg/kg LEV-administered group. Glutathione, superoxide dismutase, and catalase levels were significantly decreased in all experimental groups while malondialdehyde levels were significantly increased in 150 and 300 mg/kg LEV-administered groups. According to these results, it was determined that LEV administration decreased sperm quality and it was alleged that hormonal alteration and oxidative stress are potential contributors to reproductive toxicity.
Highlights
Reproductive toxicity has increased in recent years because of enhanced exposure to chemicals like environmental pollutants, industrial products, and pharmaceuticals [1]
It is very important to determine the toxic effects of antiepileptic drugs that are frequently used in patients of reproductive age, during reproductive development and maturation processes [9]
We evaluated the reproductive toxicity of LEV in male rats, independently of other risk factors related to infertility, and with repeated pharmacological dosing
Summary
Reproductive toxicity has increased in recent years because of enhanced exposure to chemicals like environmental pollutants, industrial products, and pharmaceuticals [1]. Infertility is becoming the focus of interest among all reproductive toxic effects [2]. Results of epidemiological studies have suggested that approximately 50% of infertility cases are due to male-related factors. Reproductive toxicity occurs in epilepsy patients owing to the drugs used in treatment, as well as the disease itself [4, 5]. Reproductive dysfunction is observed in 22–67% of males with epilepsy. It is suggested that seizures and antiepileptic drugs change hormone levels and cause reproductive dysfunction by affecting the hypothalamic-pituitary-gonadal axis [6, 7]. It is very important to determine the toxic effects of antiepileptic drugs that are frequently used in patients of reproductive age, during reproductive development and maturation processes [9]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.